Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy.
Spinal muscular atrophy (SMA) is a devastating neurodegenerative disorder that causes progressive muscle atrophy and weakness. Using adeno-associated virus-mediated gene transfer, we evaluated the potential to improve skeletal muscle weakness via systemic, postnatal inhibition of either myostatin or...
Main Authors: | Min Liu, David W Hammers, Elisabeth R Barton, H Lee Sweeney |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5117715?pdf=render |
Similar Items
-
The function of Activin receptor type IIB signaling in adult skeletal muscle
by: Relizani, Karima
Published: (2014) -
Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
by: Matthew E.R. Butchbach, et al.
Published: (2007-08-01) -
Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy
by: Elina Millere, et al.
Published: (2021-01-01) -
Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model.
by: Tero Puolakkainen, et al.
Published: (2017-01-01) -
Understanding the Pathophysiology of Spinal Muscular Atrophy Skeletal Muscle
by: Boyer, Justin
Published: (2013)